|
|
|
|
|
| | Product Pipeline | Product Portfolio   |
| Cardiovascular Diseases | Central Nervous System Disorders | Infectious Diseases | | Arthritis/Inflammation | Metabolic Diseases | Allergic Diseases | | Cancer | Genitourinary/Sexual Health | Surgery/Interventional | | Consumer Health/OTC | Animal Health | | |
| ||
| MAJOR PFIZER PRODUCTS AND SELECTED CANDIDATES IN DEVELOPMENT | ||
| Infectious Diseases | ||
| Current Products | ||
| Bacacil/Spectrobid Cefobid Diflucan Diflucan [I] (for onychomycosis) Diflucan (for pediatric use) Diflucan VC (for vaginal candidiasis) Fasigyn [I] streptomycin Sulperazon [I] Terramycin Trosyd [I] |
Trovan Tablets/IV [U.S.] (antibiotic for the treatment of lower and upper respiratory tract infections, intra-abdominal and pelvic infections, gonorrhea, chlamydial cervicitis, uncomplicated UTIs, skin and soft tissue infections, and chronic prostatitis) Unasyn IM/IV Unasyn Oral [I] Vibramycin |
Zithromax Zithromax POS (for pediatric use in treating otitis media, pharyngitis, and community-acquired pneumonia) Zithromax SDP (for Chlamydia) Zithromax [U.S.] (lower and upper respiratory tract infections, urethritis and cervicitis due to Chlamydia trachomatis or N. gonorrheae, chancoid, MAC prophylaxis, uncomplicated skin and skin structure infections) Zithromax IV [U.S.] (for community-acquired pneumonia and pelvic inflammatory disease) |
| Extensions / Additional Indications (last 12 months) | Under Regulatory Review | In Advanced-Stage Development |
|
Unasyn [U.S.] (for pediatric use) Zithromax 600 for MAC (for prevention of Mycobacterium avium complex [AIDS related]) Zithromax IV [U.S.] (for community-acquired pneumonia and PID) |
Trovan (trovafloxacin) [I] (for bacterial infections) Trovan IV (alatrofloxacin) [I] (IV form of trovafloxacin) |
UK-292,663 (antifungal) voriconazole (for serious fungal infections) Zithromax (for prevention of progression of coronary artery disease) Zithromax 600 for MAC (for treatment of Mycobacterium avium complex [AIDS related]) |
| Key: [U.S.]—U.S. only [I]—International only (in at least one country) No Key—Both U.S. and at least one other country | ||
|
|
|
| ||||
 |
 |
 |
 | |
| ||||
 |
||||
 |
||||
| Advisory Information for Investors | ||||
| Copyright © 1997, 1998 Pfizer Inc All rights reserved. | ||||
| ||||